Dean J. Mitchell

Director at Theravance Biopharma · 6 reported transactions in 2 companies · latest report Sep 23, 2026

Their trades


Theravance BiopharmaTBPH	Returned to company — · 6,009 shares	Sep 23, 2026
Theravance BiopharmaTBPH	Returned to company — · 91,204 shares	Sep 23, 2026
Theravance BiopharmaTBPH	Share award — · 6,009 shares	Jun 12, 2026
Praxis Precision MedicinesPRAX	Exercised options $77.2K · 1,753 shares	Sep 24, 2025
Praxis Precision MedicinesPRAX	Exercised options $379K · 8,566 shares	Sep 24, 2025
Praxis Precision MedicinesPRAX	Exercised options $27.7K · 1,932 shares	Sep 24, 2025

Sep 23, 2026 · TBPH

6,009

Sep 23, 2026 · TBPH

91,204

Jun 12, 2026 · TBPH

6,009

Sep 24, 2025 · PRAX

$77.2K

Sep 24, 2025 · PRAX

$379K

Sep 24, 2025 · PRAX

$27.7K

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Theravance Biopharma · 6 reported transactions in 2 companies · latest report Sep 23, 2026


Theravance BiopharmaTBPH	Returned to company — · 6,009 shares	Sep 23, 2026
Theravance BiopharmaTBPH	Returned to company — · 91,204 shares	Sep 23, 2026
Theravance BiopharmaTBPH	Share award — · 6,009 shares	Jun 12, 2026
Praxis Precision MedicinesPRAX	Exercised options $77.2K · 1,753 shares	Sep 24, 2025
Praxis Precision MedicinesPRAX	Exercised options $379K · 8,566 shares	Sep 24, 2025
Praxis Precision MedicinesPRAX	Exercised options $27.7K · 1,932 shares	Sep 24, 2025